Arteriosclerosis Derived from Cutaneous Inflammation Is Ameliorated by the Deletion of IL-17A and IL-17FTakehisa Nakanishi, Keiichi Yamanaka, Yoichiro Iwakura et al.|International Journal of Molecular Sciences|2023Cited by 9
The Interplay of Type 1, Type 2, and Type 3 Lymphocytes and Cytokines in Atopic DermatitisKeiichi Yamanaka, Yasutomo Imai, Yui Kono et al.|International Journal of Molecular Sciences|2023Cited by 9
A Case of Pruritic Urticarial Papules and Plaques of Pregnancy: Pathophysiology and Serum Cytokine ProfileMai Nishimura, Keiichi Yamanaka, Makoto Kondo et al.|Case Reports in Dermatology|2021Cited by 6
Increased Mortality Risk at Septic Condition in Inflammatory Skin Disorders and the Effect of High-Fat Diet ConsumptionMai Nishimura, Keiichi Yamanaka, Takehisa Nakanishi et al.|International Journal of Molecular Sciences|2023Cited by 5
Amelioration of Systemic Amyloidosis by Blocking IL-17A and Not by IL-17F, and Arteriosclerosis by Blocking Both IL-17A and IL-17F in an Inflammatory Skin Mouse ModelTakehisa Nakanishi, Keiichi Yamanaka, Shohei Iida et al.|International Journal of Molecular Sciences|2024Cited by 2